{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:22:35Z","timestamp":1778649755573,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008658","name":"Deutsches Krebsforschungszentrum","doi-asserted-by":"publisher","award":["B300201525584"],"award-info":[{"award-number":["B300201525584"]}],"id":[{"id":"10.13039\/100008658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008658","name":"Deutsches Krebsforschungszentrum","doi-asserted-by":"publisher","award":["GST-L1-MIA"],"award-info":[{"award-number":["GST-L1-MIA"]}],"id":[{"id":"10.13039\/100008658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008658","name":"Deutsches Krebsforschungszentrum","doi-asserted-by":"publisher","award":["B300201525585"],"award-info":[{"award-number":["B300201525585"]}],"id":[{"id":"10.13039\/100008658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"University of Antwerp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["101040588"],"award-info":[{"award-number":["101040588"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016882","name":"European Resuscitation Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["11PJK24N"],"award-info":[{"award-number":["11PJK24N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jviromet.2024.115003","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T19:22:34Z","timestamp":1722021754000},"page":"115003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Time-resolved fluorescence (TRF) for total IgG and HPV16-specific antibody detection in first-void urine and serum: A comparative study"],"prefix":"10.1016","volume":"329","author":[{"given":"Marijana","family":"Lipovac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"T\u00e9blick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margo","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Van Caesbroeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemie","family":"De Smet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Severien","family":"Van Keer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Delputte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse","family":"De Coster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiebren A.A.","family":"Tjalma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Vorsters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2024.115003_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph182413314","article-title":"Diagnostic test accuracy of first-void urine human papillomaviruses for presence cervical HPV in women: systematic review and meta-analysis","volume":"18","author":"Bober","year":"2021","journal-title":"Int. J. Environ. Res Public Health"},{"key":"10.1016\/j.jviromet.2024.115003_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13690-021-00667-4","article-title":"Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study","volume":"79","author":"De Pauw","year":"2021","journal-title":"Arch. Public Health"},{"key":"10.1016\/j.jviromet.2024.115003_bib3","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2024.115003_bib4","series-title":"Human Papillomavirus Laboratory Manual","first-page":"1","author":"Ferguson","year":"2009"},{"key":"10.1016\/j.jviromet.2024.115003_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4161\/mabs.3.2.14858","article-title":"Molecular characterization of the cervical and systemic B-cell repertoire: unique, yet overlapping, immune compartments of an HIV-1 resistant individual","volume":"3","author":"Gaudet","year":"2011","journal-title":"MAbs"},{"key":"10.1016\/j.jviromet.2024.115003_bib6","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/cncr.23764","article-title":"HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women","volume":"113","author":"Gillison","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jviromet.2024.115003_bib7","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1007\/s00216-011-5047-7","article-title":"Lanthanide-based time-resolved luminescence immunoassays","volume":"400","author":"Hagan","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jviromet.2024.115003_bib8","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/CVI.00039-11","article-title":"Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay","volume":"18","author":"Kavanagh","year":"2011","journal-title":"Clin. Vaccin. Immunol."},{"key":"10.1016\/j.jviromet.2024.115003_bib9","series-title":"Collaborative Study to Evaluate Candidate 1st WHO International Standards for Antibodies to Human Papillomavirus Types 6, 11, 31, 33, 45, 52 and 58","first-page":"1","author":"Kemp","year":"2022"},{"key":"10.1016\/j.jviromet.2024.115003_bib10","doi-asserted-by":"crossref","first-page":"13253","DOI":"10.1128\/JVI.06093-11","article-title":"A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection","volume":"85","author":"Longet","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2024.115003_bib11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0897.2005.00267.x","article-title":"Immunologic uniqueness of the genital tract: challenge for vaccine development","volume":"53","author":"Mestecky","year":"2005","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jviromet.2024.115003_bib12","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/jnci\/djg018","article-title":"Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles","volume":"95","author":"Nardelli-Haefliger","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jviromet.2024.115003_bib13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2024.115003_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jim.2014.12.013","article-title":"Development and evaluation of multiplexed immunoassay for detection of antibodies to HPV vaccine types","volume":"417","author":"Panicker","year":"2015","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jviromet.2024.115003_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113136","article-title":"Multiplex immunoassay to measure antibody response to nine HPV vaccine types","volume":"498","author":"Panicker","year":"2021","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jviromet.2024.115003_bib16","doi-asserted-by":"crossref","first-page":"g5264","DOI":"10.1136\/bmj.g5264","article-title":"Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis","volume":"349","author":"Pathak","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jviromet.2024.115003_bib17","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1002\/jmv.25841","article-title":"Comparison of a VLP-based and GST-L1-based multiplex immunoassay to detect vaccine-induced HPV-specific antibodies in first-void urine","volume":"92","author":"Pattyn","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jviromet.2024.115003_bib18","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3389\/fimmu.2020.01657","article-title":"Non-invasive assessment of vaccine-induced HPV antibodies via first-void urine","volume":"11","author":"Pattyn","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jviromet.2024.115003_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ebiom.2016.06.042","article-title":"A Single human papillomavirus vaccine dose improves B cell memory in previously infected subjects","volume":"10","author":"Scherer","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jviromet.2024.115003_bib20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4161\/hv.22693","article-title":"Detection of systemic and mucosal HPV-specific IgG and IgA antibodies in adolescent girls one and two years after HPV vaccination","volume":"9","author":"Scherpenisse","year":"2013","journal-title":"Hum. Vaccin Immunother."},{"issue":"Suppl 5","key":"10.1016\/j.jviromet.2024.115003_bib21","doi-asserted-by":"crossref","first-page":"F83","DOI":"10.1016\/j.vaccine.2012.04.106","article-title":"Human papillomavirus vaccines--immune responses","volume":"30","author":"Stanley","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2024.115003_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1128\/CVI.00457-14","volume":"22","author":"Struyf","year":"2015","journal-title":"Clin. Vaccin. Immunol."},{"issue":"1","key":"10.1016\/j.jviromet.2024.115003_bib23","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2330168","article-title":"HPV-specific antibodies in female genital tract secretions captured via first-void urine retain their neutralizing capacity","volume":"20","author":"Teblick","year":"2024","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.jviromet.2024.115003_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29133","article-title":"Follow-up of humoral immune response after HPV vaccination using first-void urine: a longitudinal cohort study","volume":"95","author":"Teblick","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jviromet.2024.115003_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016741","article-title":"Using time-resolved fluorescence to measure serum venom-specific IgE and IgG","volume":"6","author":"Van Eeden","year":"2011","journal-title":"PLOS One"},{"key":"10.1016\/j.jviromet.2024.115003_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2022.105271","article-title":"Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: a diagnostic test accuracy study","volume":"155","author":"Van Keer","year":"2022","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2024.115003_bib27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ygyno.2021.06.010","article-title":"Clinical and analytical evaluation of the realtime high risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol","volume":"162","author":"Van Keer","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jviromet.2024.115003_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jcv.2019.05.004","article-title":"First-void urine as a non-invasive liquid biopsy source to detect vaccine-induced human papillomavirus antibodies originating from cervicovaginal secretions","volume":"117","author":"Van Keer","year":"2019","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2024.115003_bib29","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","article-title":"High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine through 5 years of follow-up","volume":"95","author":"Villa","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jviromet.2024.115003_bib30","doi-asserted-by":"crossref","first-page":"g6252","DOI":"10.1136\/bmj.g6252","article-title":"Urine testing for HPV: rationale for using first void","volume":"349","author":"Vorsters","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jviromet.2024.115003_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.jviromet.2024.115003_bib32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jim.2005.11.008","article-title":"Suppression of non-specific binding in serological Luminex assays","volume":"309","author":"Waterboer","year":"2006","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jviromet.2024.115003_bib33","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1373\/clinchem.2005.052381","article-title":"Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins","volume":"51","author":"Waterboer","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jviromet.2024.115003_bib34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.it.2018.01.007","article-title":"Immunology of the uterine and vaginal mucosae","volume":"39","author":"Zhou","year":"2018","journal-title":"Trends Immunol."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093424001277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093424001277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:05:23Z","timestamp":1777496723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093424001277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":34,"alternative-id":["S0166093424001277"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2024.115003","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time-resolved fluorescence (TRF) for total IgG and HPV16-specific antibody detection in first-void urine and serum: A comparative study","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2024.115003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115003"}}